Biotech Innovation and CSR: Navigating Pandemic Crises to Protect Shareholder Value

Retrieved on: 2025-09-19 18:39:06

Tags for this article:

Click the tags to see associated articles and topics

Biotech Innovation and CSR: Navigating Pandemic Crises to Protect Shareholder Value. View article details on hiswai:

Excerpt

- Pandemic-focused firms like BioNTech and Moderna saw 35% revenue growth in 2021, while smaller companies faced liquidity crises, highlighting ...

Article found on: www.ainvest.com